Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight.
The “Metformin Drugs Industry Forecast” looks at past sales and reviews total world Metformin Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Metformin Drugs sales for 2023 through 2029. With Metformin Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metformin Drugs industry.
This Insight Report provides a comprehensive analysis of the global Metformin Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metformin Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Metformin Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metformin Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metformin Drugs.
The global Metformin Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Metformin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Metformin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Metformin Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Metformin Drugs players cover Novartis, Apotex, Mylan, Mallinckrodt, Teva Pharmaceuticals, Alkem, Dr. Reddy’s Laboratories, Atlas Pharmaceuticals and Sun Pharmaceutical Industries, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Metformin Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
50 Tablets
100 Tablets
Other
Segmentation by application
Hospital
Drugs Stores
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Apotex
Mylan
Mallinckrodt
Teva Pharmaceuticals
Alkem
Dr. Reddy’s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol-Myers Squibb
Key Questions Addressed in this Report
What is the 10-year outlook for the global Metformin Drugs market?
What factors are driving Metformin Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metformin Drugs market opportunities vary by end market size?
How does Metformin Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metformin Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Metformin Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Metformin Drugs by Country/Region, 2018, 2022 & 2029
2.2 Metformin Drugs Segment by Type
2.2.1 50 Tablets
2.2.2 100 Tablets
2.2.3 Other
2.3 Metformin Drugs Sales by Type
2.3.1 Global Metformin Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Metformin Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Metformin Drugs Sale Price by Type (2018-2023)
2.4 Metformin Drugs Segment by Application
2.4.1 Hospital
2.4.2 Drugs Stores
2.5 Metformin Drugs Sales by Application
2.5.1 Global Metformin Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Metformin Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Metformin Drugs Sale Price by Application (2018-2023)
3 Global Metformin Drugs by Company
3.1 Global Metformin Drugs Breakdown Data by Company
3.1.1 Global Metformin Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Metformin Drugs Sales Market Share by Company (2018-2023)
3.2 Global Metformin Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Metformin Drugs Revenue by Company (2018-2023)
3.2.2 Global Metformin Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Metformin Drugs Sale Price by Company
3.4 Key Manufacturers Metformin Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metformin Drugs Product Location Distribution
3.4.2 Players Metformin Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Metformin Drugs by Geographic Region
4.1 World Historic Metformin Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Metformin Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Metformin Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Metformin Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Metformin Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Metformin Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Metformin Drugs Sales Growth
4.4 APAC Metformin Drugs Sales Growth
4.5 Europe Metformin Drugs Sales Growth
4.6 Middle East & Africa Metformin Drugs Sales Growth
5 Americas
5.1 Americas Metformin Drugs Sales by Country
5.1.1 Americas Metformin Drugs Sales by Country (2018-2023)
5.1.2 Americas Metformin Drugs Revenue by Country (2018-2023)
5.2 Americas Metformin Drugs Sales by Type
5.3 Americas Metformin Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metformin Drugs Sales by Region
6.1.1 APAC Metformin Drugs Sales by Region (2018-2023)
6.1.2 APAC Metformin Drugs Revenue by Region (2018-2023)
6.2 APAC Metformin Drugs Sales by Type
6.3 APAC Metformin Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Metformin Drugs by Country
7.1.1 Europe Metformin Drugs Sales by Country (2018-2023)
7.1.2 Europe Metformin Drugs Revenue by Country (2018-2023)
7.2 Europe Metformin Drugs Sales by Type
7.3 Europe Metformin Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metformin Drugs by Country
8.1.1 Middle East & Africa Metformin Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Metformin Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Metformin Drugs Sales by Type
8.3 Middle East & Africa Metformin Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metformin Drugs
10.3 Manufacturing Process Analysis of Metformin Drugs
10.4 Industry Chain Structure of Metformin Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metformin Drugs Distributors
11.3 Metformin Drugs Customer
12 World Forecast Review for Metformin Drugs by Geographic Region
12.1 Global Metformin Drugs Market Size Forecast by Region
12.1.1 Global Metformin Drugs Forecast by Region (2024-2029)
12.1.2 Global Metformin Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metformin Drugs Forecast by Type
12.7 Global Metformin Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Metformin Drugs Product Portfolios and Specifications
13.1.3 Novartis Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Apotex
13.2.1 Apotex Company Information
13.2.2 Apotex Metformin Drugs Product Portfolios and Specifications
13.2.3 Apotex Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Apotex Main Business Overview
13.2.5 Apotex Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Metformin Drugs Product Portfolios and Specifications
13.3.3 Mylan Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Mallinckrodt
13.4.1 Mallinckrodt Company Information
13.4.2 Mallinckrodt Metformin Drugs Product Portfolios and Specifications
13.4.3 Mallinckrodt Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mallinckrodt Main Business Overview
13.4.5 Mallinckrodt Latest Developments
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Information
13.5.2 Teva Pharmaceuticals Metformin Drugs Product Portfolios and Specifications
13.5.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceuticals Main Business Overview
13.5.5 Teva Pharmaceuticals Latest Developments
13.6 Alkem
13.6.1 Alkem Company Information
13.6.2 Alkem Metformin Drugs Product Portfolios and Specifications
13.6.3 Alkem Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alkem Main Business Overview
13.6.5 Alkem Latest Developments
13.7 Dr. Reddy’s Laboratories
13.7.1 Dr. Reddy’s Laboratories Company Information
13.7.2 Dr. Reddy’s Laboratories Metformin Drugs Product Portfolios and Specifications
13.7.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dr. Reddy’s Laboratories Main Business Overview
13.7.5 Dr. Reddy’s Laboratories Latest Developments
13.8 Atlas Pharmaceuticals
13.8.1 Atlas Pharmaceuticals Company Information
13.8.2 Atlas Pharmaceuticals Metformin Drugs Product Portfolios and Specifications
13.8.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Atlas Pharmaceuticals Main Business Overview
13.8.5 Atlas Pharmaceuticals Latest Developments
13.9 Sun Pharmaceutical Industries
13.9.1 Sun Pharmaceutical Industries Company Information
13.9.2 Sun Pharmaceutical Industries Metformin Drugs Product Portfolios and Specifications
13.9.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sun Pharmaceutical Industries Main Business Overview
13.9.5 Sun Pharmaceutical Industries Latest Developments
13.10 Torrent Pharmaceuticals
13.10.1 Torrent Pharmaceuticals Company Information
13.10.2 Torrent Pharmaceuticals Metformin Drugs Product Portfolios and Specifications
13.10.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Torrent Pharmaceuticals Main Business Overview
13.10.5 Torrent Pharmaceuticals Latest Developments
13.11 Bristol-Myers Squibb
13.11.1 Bristol-Myers Squibb Company Information
13.11.2 Bristol-Myers Squibb Metformin Drugs Product Portfolios and Specifications
13.11.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bristol-Myers Squibb Main Business Overview
13.11.5 Bristol-Myers Squibb Latest Developments
14 Research Findings and Conclusion
*If Applicable.